At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 350 enrolled
Drug / intervention
ABT-981 +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis
In Brief
A Phase 2 clinical trial evaluating ABT-981 and Placebo for Knee Osteoarthritis and Medial Compartment Knee Osteoarthritis. Completed, enrolled 350 participants.
Detailed Summary
A Phase 2a, multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the safety, tolerability, efficacy and pharmacokinetic/pharmacodynamic effect of ABT-981 in patients with symptomatic, radiographic, and inflammatory knee osteoarthritis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartJun 2014
Primary CompletionJun 2016
Study CompletionDec 2016
TodayJul 2026
First PostedMar 14, 2014
Enrollment StartJun 4, 2014
Primary CompletionJun 7, 2016
Study CompletionDec 13, 2016
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 12.3 years ago
Interventions
ABT-981biological
Placeboother